| Submission declined on 20 December 2023 by KylieTastic (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 19 July 2023 by Theroadislong (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Theroadislong 10 months ago.
| |
Nutriband Inc (Nasdaq:NTRB) is a publicly traded company specializing in the development and commercialization of innovative transdermal pharmaceutical and supplement products. The company has positioned itself as a key player in the development of abuse deterrent transdermal technologies for transdermal opioids, such as fentanyl.
Founding and History edit
Nutriband Inc. was founded in 2012 by Gareth Sheridan and Serguei Melnik. The company's mission is to enhance the well-being of individuals by creating products that address health challenges through advanced transdermal delivery systems. Over the years, Nutriband has expanded its product portfolio and market presence through strategic partnerships and collaborations.
AVERSA™ edit
At the forefront of Nutriband's offerings is the AVERSA™ technology, strategically designed to prevent misuse and abuse of drugs with abuse potential, specifically opioids. The company's initial application of AVERSA™ targets the development of an abuse deterrent fentanyl transdermal patch. This groundbreaking technology aims to provide clinicians and patients with extended-release chronic pain relief while ensuring the safety of these treatments. Nutriband envisions a future where pain management is not only effective but also safe for all individuals in need.
Subsidiaries edit
Nutriband Inc has two subsidiaries, 4P Therapeutics and Pocono Pharmaceutical. Nutriband acquired 4P Therapeutics in 2018[1]. 4P Therapeutics is a clinical subsidiary of Nutriband Inc. and is focused on the research and development of novel drug delivery technologies and therapeutics. Nutriband acquired Pocono Pharmaceutical in 2020[2]. Pocono Pharmaceutical is a contract manufacturing subsidiary in the area of coated materials, Consulting, Formulations and manufacturing.
Research and Development edit
Nutriband Inc. actively engages in contract research and development services, channeling its commitment to innovation and pharmaceutical advancement through its subsidiary, 4P Therapeutics. As a trusted partner in the life sciences field, 4P Therapeutics collaborates with diverse clients to provide tailored solutions that contribute to the evolution of drug delivery technologies.
Nutriband, via 4P Therapeutics, stands at the forefront of transdermal drug delivery research. The subsidiary's emphasis on patch technologies represents a commitment to patient-centric alternatives, aiming to enhance compliance and improve treatment outcomes. This spans from conventional transdermal systems to innovative technologies capable of delivering a wide range of substances, including peptides, proteins, and vaccines.
Emphasizing a collaborative and supportive approach, 4P Therapeutics specializes in expediting products from concept to commercialization. The subsidiary efficiently moves from establishing preclinical feasibility to demonstrating proof-of-concept in human trials. Following this, 4P Therapeutics actively guides the execution of the clinical and regulatory program, facilitates the tech transfer process, supports design for manufacturing, and manages crucial contract manufacturing relationships during scale-up and commercialization.
Contract Manufacturing edit
Pocono Pharmaceutical serves as a trusted contract manufacturer and consultant specializing in matrix coated products, topicals, and cosmetics. With a commitment to quality and precision, Pocono Pharmaceutical offers in-house production capabilities and a range of services for clients seeking to develop or launch new coated products.
While Pocono Pharmaceutical does not actively participate in the regulatory process on behalf of clients, the company maintains a collaborative approach by referring customers to 4P Therapeutics for regulatory services. This ensures that clients have access to comprehensive regulatory support and guidance when needed.
References edit
- ^ Taylor, Charlie. "Irish-founded Nutriband completes $2.25m deal for 4P Therapeutics". Irish Times.
- ^ "Nutriband Acquires Transdermal and Health Product Manufacturing Business". Contract Pharma.